Pacific Biosciences of California Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.66 |
Market Cap |
EUR824.45 M |
Shares Outstanding |
131.94 M |
Public Float |
119.36 M |
Pacific Biosciences of California Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.76 |
Market Cap |
$932.84 M |
Shares Outstanding |
152.68 M |
Public Float |
136.6 M |
Address |
1305 O'Brien Drive Menlo Park California 94025 United States |
Employees | - |
Website | http://www.pacb.com |
Updated | 07/08/2019 |
Pacific Biosciences of California, Inc. engages in the research, development, and manufacture of sequencing systems for genetic analysis. It operates through the following geographical segments: North America, Europe, and Asia Pacific (including the Middle East). The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. |